Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring
Liver International · 2026-07 · 46 (7)
DOI: 10.1111/liv.70759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 19.06.2026. Verfasst von Rola Matar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, French National Reference Center for Hepatitis B, C and D Viruses, Hôpital Henri Mondor (AP-HP), Université Paris-Est, Crétei…. Hauptthemen laut MEDLINE: Dried Blood Spot Testing, Hepatitis D, Chronic. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Chronic hepatitis D is the most severe form of viral hepatitis. Despite recommendations for systematic screening of HBsAg‐positive individuals, hepatitis D infection remains underdiagnosed. Standard HDV virological markers are classically assessed in serum or plasma specimens obtained through venous whole blood sampling. This approach is costly and challenging in resource‐limited settings. Dried blood spot (DBS) sampling offers a practical alternative for large‐scale screening, diagnosis, and monitoring of viral hepatitis. The goal of the study is to evaluate the performance of commercially available HDV diagnostic assays using DBS.
Methods
Plasma and DBS‐collected whole blood specimens from individuals chronically infected with HBV or coinfected with HBV and HDV were analysed for HDV antibody detection, HDV RNA quantification, HBsAg levels, and HDV genotyping.
Results
HDV antibodies were reliably detected in DBS after threshold adjustment, with the LIAISON XL Murex Anti‐HDV assay showing superior sensitivity (99.3%) compared to HDV Ab DIA.PRO (90.3%), while both assays exhibited excellent specificity. HDV RNA was quantifiable in 86.8% of DBS specimens from patients with active infection, although levels were about 1.5 log 10 lower than plasma, showing a strong correlation ( r = 0.786; p < 0.0001). HBsAg was detectable and quantifiable in all DBS samples, correlating closely with plasma values ( r = 0.98). DBS‐based HDV genotyping was successful in 84.8% of samples and concordant with plasma results.
Conclusions
DBS collection of whole blood from DBS appears to be a promising and practical alternative to conventional venous blood sampling for HDV screening, diagnosis, and monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology, French National Reference Center for Hepatitis B, C and D Viruses, Hôpital Henri Mondor (AP-HP), Université Paris-Est, Créteil, France.
- "Team Viruses, Hepatology, Cancer" Institut de Recherche Biomédicale, INSERM U955, Créteil, France.
- Department of Hepatology, Hôpital Henri Mondor (AP-HP), Créteil, France.
ORCID-Profile: Daniel Candotti, Jean-Michel Pawlotsky, Stéphane Chevaliez
Zitieren
APA
Matar, R., Roudot-Thoraval, F., Ortonne, V., Garrigou, O., Soulier, A., Cappy, P., Candotti, D., Ingiliz, P., Pawlotsky, J. M., Leroy, V., & Chevaliez, S. (2026). Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring. Liver International, 46(7). https://doi.org/10.1111/liv.70759
Vancouver
Matar R, Roudot-Thoraval F, Ortonne V, Garrigou O, Soulier A, Cappy P, et al. Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring. Liver International. 2026;46(7). doi:10.1111/liv.70759
BibTeX
@article{Matar2026,
author = {Matar, Rola and Roudot-Thoraval, Françoise and Ortonne, Valérie and Garrigou, Olivia and Soulier, Alexandre and Cappy, Pierre and Candotti, Daniel and Ingiliz, Patrick and Pawlotsky, Jean-Michel and Leroy, Vincent and Chevaliez, Stéphane},
title = {Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring},
journal = {Liver International},
year = {2026},
volume = {46},
number = {7},
doi = {10.1111/liv.70759}
}
EUVIMED